Quantcast

Latest Cisplatin Stories

2009-06-02 08:15:36

Daqing Li and colleagues, at the University of Pennsylvania School of Medicine, Philadelphia, have identified in vitro and in mice a way to enhance the anticancer effects of the commonly used platinum-based drug cisplatin. For many forms of cancer, including testicular, ovarian, and lung cancer, platinum-based drugs that cause DNA damage are the first choice treatment. However, the utility of these drugs is often limited by the enhanced ability of cancer cells to repair their DNA. As the...

2009-05-31 07:30:00

ORLANDO, Fla., May 31 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today that Phase III trial data showed the addition of Lilly's GEMZAR(R) (gemcitabine HCl for injection) to the current standard of care provided a statistically significant increase in progression-free survival at three years for women with locally advanced cervical cancer. Cervical cancer is the world's second most commonly diagnosed women's cancer, and the second most common cause of cancer death in...

2009-05-29 12:09:00

INDIANAPOLIS, May 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of ALIMTA(R) (pemetrexed for injection) as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with other than predominantly squamous cell histology in patients whose disease has not progressed...

2009-05-12 07:00:00

INDIANAPOLIS, May 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) will unveil data from more than 50 studies at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Fla. from May 29 to June 2, 2009, with the majority of the presentations continuing to support Lilly's leadership in thoracic cancer research. The company will present the latest research findings on ALIMTA(R) (pemetrexed for injection), as well as GEMZAR(R) (gemcitabine HCl for...

2009-04-30 13:00:00

FREDERICK, Md., April 30 /PRNewswire/ -- Royer Animal Health, LLC, a wholly owned subsidiary of Royer Biomedical, Inc., has executed an exclusive distribution agreement with MWI Veterinary, Supply, Inc. (Nasdaq: MWIV) to market its lead animal health products: MATRIX III CISPLATIN BEADS and R-GEL ANTIBIOTIC WOUND DRESSING. These proprietary, timed-release products provide veterinary professionals with localized treatment options for cancer, infections, and general wound management. By...

2009-03-20 06:00:00

ZURICH, Switzerland, March 20 /PRNewswire/ -- A new, innovative study shows that a single dose of palonosetron, the second generation 5-HT3 antagonist, plus dexamethasone not only prevents chemotherapy-induced nausea and vomiting (CINV), but also allows adequate caloric intake in oncology patients. Data presented today at the ESMO Symposium on Cancer and Nutrition in Zurich, Switzerland New data presented today at the ESMO (European Society of Medical Oncology) Symposium on Cancer...

2009-03-11 07:26:01

Breast cancer patients face many horrors, including those that arise when fighting the cancer itself. Medications given during chemotherapy can have wicked side effects, including vomiting, dizziness, anemia and hair loss. These side effects occur because medications released into the body target healthy cells as well as tumor cells.The trick becomes how to deliver cancer-fighting drugs directly to the tumor cells. Brown University chemists think they have an answer: They have created a twin...

2009-01-13 13:05:13

For years, research has hinted that the time of day that cancer patients receive chemotherapy can impact their chances of survival. But the lack of a clear scientific explanation for this finding has kept clinicians from considering timing as a factor in treatment. Now, a new study from the University of North Carolina at Chapel Hill has suggested that treatment is most effective at certain times of day because that is when a particular enzyme system "“ one that can reverse the actions...

2008-12-09 19:18:24

A precious metal never used in a clinical setting is being developed as a next-generation cancer treatment, British researchers report. University of Warwick researchers are working with the metal, osmium, which is related to platinum and is used to treat cancers as part of the drug cisplatin, the university said in a news release. The Department of Chemistry researchers are seeking partners to help develop osmium through more extensive biological tests. While cisplatin is successful...

2008-11-20 15:22:40

Phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than other drugs, U.S. researchers said. The new class of compounds could be less harmful than current cancer treatments on the market such as cisplatin and carboplatin because they don't penetrate the cell nucleus and attach to DNA, said lead author Rathindra Bose, who conducted the work while at Northern Illinois University. Conventional drugs can interfere with the functions...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.